Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published
Bromhidrosis Treatment Modalities: A Literature Review.
Treatment options for Bromhidrosis include Botulinum toxin therapy, microwave-based therapy, laser therapy, and surgerical intervention. There have been limited studies comparing their efficacies.The purpose of this literature review is to …
Small molecule inhibitors and biologics in treating nail psoriasis: a systematic review and network meta-analysis.
Various systemic immunomodulating therapies have been investigated to treat nail psoriasis, but the efficacy remains unclear.To perform a systematic review and network meta-analysis (NMA) to evaluate the efficacy of small …
An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology.
Immune-mediated diseases and immunotherapeutics can negatively impact normal immune functioning and consequently vaccine safety and response. The COVID-19 pandemic has incited research aimed at developing a novel SARS-CoV-2 vaccine. As …
Aspirin Use Cuts CRC Risk in Those Initiating Use Before Age 70
Inverse association seen for aspirin users starting use before age 70, but not for those initiating use at or after age 70 years
2.3 Percent of Kindergarteners Not Up to Date With MMR in 2019-2020
2.5 percent of kindergartners had an exemption, but additional 2.3 percent were not up to date and had no exemption
Non-Hispanic Blacks Underrepresented on Transplant Wait List
However, racial disparities in liver transplantation are greatly diminished
Patient Age Linked to Choice of Telepsychiatry Visit Type
Patients aged 44 years and older more likely to opt for telephone visits; telephone visit users less likely to anticipate future televisits
Hahn Resigns as Head of FDA, Dr. Janet Woodcock New Interim Chief
A permanent FDA commissioner has not yet been nominated, but Woodcock is under consideration